Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00410982
Status:
COMPLETED
Last Update Posted:
2016-06-03
First Post:
2006-12-11
Brief Title:
Gemcitabine Plus Busulfan Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myeloma |
| Leukemia |
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| Alkeran | View |
| Lymphoid Malignancies | View |
| Hodgkins Disease | View |
| Non-Hodgkins Lymphoma | View |
| Acute Lymphoblastic Leukemia | View |
| Chronic Lymphocytic Leukemia | View |
| Hematopoietic Cell Transplantation | View |
| Myeloma | View |
| Leukemia | View |
| Lymphoma | View |
| Busulfan | View |
| Busulfex | View |
| Myleran | View |
| Gemcitabine | View |
| Gemcitabine Hydrochloride | View |
| Gemzar | View |
| Melphalan | View |